TD Asset Management
MIST icon

TD Asset Management’s Milestone Pharmaceuticals MIST Stock Holding History

TD Asset Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,704
Closed -$108K – 1549
2021
Q1 		$108K Sell
18,704
-4,361
-19% -$31.9K ﹤0.01% 1482
2020
Q4 		$155K Hold
23,065
– – ﹤0.01% 1426
2020
Q3 		$169K Hold
23,065
– – ﹤0.01% 1343
2020
Q2 		$87K Hold
23,065
– – ﹤0.01% 1316
2020
Q1 		$42K Sell
23,065
-13,200
-36% -$229K ﹤0.01% 1357
2019
Q4 		$581K Hold
36,265
– – ﹤0.01% 1215
2019
Q3 		$627K Buy
+36,265
New +$714K ﹤0.01% 1141

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

TD Asset Management's MIST Position: Q2 2021 in Review

TD Asset Management sold out of Milestone Pharmaceuticals (MIST) in Q2 2021, closing a stake of 18,704 shares — an estimated $108K sold.

TD Asset Management first reported a position in MIST in Q3 2019 and held it in 7 quarters. The position peaked at $627K in Q3 2019. 28 funds tracked by Wall St. Rank hold MIST as of Q2 2021.

  • TD Asset Management reported no remaining Milestone Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • TD Asset Management sold 18,704 Milestone Pharmaceuticals shares in Q2 2021, an estimated $108K.
  • TD Asset Management first reported a position in Milestone Pharmaceuticals in Q3 2019 and held it in 7 quarters.
  • TD Asset Management's Milestone Pharmaceuticals position peaked at $627K in Q3 2019.
  • 28 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2021.

Based on TD Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.